Catalyst Wire Dossier Catalyst Wire Dossier

Cabotamig

ARB202 · Arbele Pty Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cabotamig, covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients [Phase 1]

See pricing